Výsledky vyhledávání - "Pritesh R. Patel"

Akademický článek

Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration

Autor: José Carnot Uria, Calixto Hernández Cruz, Jorge Muñío Perurena, Wilfredo Torres Yribar, Jesús Diego de la Campa, Concepción del Castillo Carrillo, Yusaima Rodríguez Fraga, Julio A. López Silva, Kali Cepero Llauger, Ibis K. Pardo Ramírez, Aliette García García, Karen Sweiss, Pritesh R. Patel, Damiano Rondelli

Publikováno v: Journal of Global Oncology, Vol 4, Pp 1-7 (2018)

Blood and marrow transplantation (BMT) has been performed in Cuba for over 30 years with limited resources and without international relationships. Researchers from University of Illinois at Chicago and Hermanos Ameijeiras Hospital (HAH) in Havana co

Externí odkaz: https://doaj.org/article/381b9cc37c6b491582db40111a31c9af

Zobrazit plný text záznamu

Trend in Tyrosine Kinase Inhibitor Utilization, Price, and Out-of-Pocket Costs in Patients With Chronic Myelogenous Leukemia

Autor: Pritesh R. Patel, Gregory S. Calip, Todd A. Lee, Brian Talon, Daniel R. Touchette, Lisa K. Sharp

Publikováno v: JCO Oncol Pract

PURPOSE: Treatment of chronic myelogenous leukemia (CML) with tyrosine kinase inhibitors (TKIs) has improved survival but is associated with significant financial burden. We measured the annual trend in TKI utilization, Medicare gross payment, and pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2581876874cf1b8dc9f91efed5913d32
https://doi.org/10.1200/op.20.00967

Zobrazit plný text záznamu

New Generation of Quinazolinone Derivatives as Potent Antimicrobial Agents

Autor: Pritesh R. Patel, Hirak Joshi, Ujash Shah, Mayank Bapna, Bhagirath Patel

Publikováno v: Asian Pacific Journal of Health Sciences. 8:61-66

Heterocyclic compounds play tremendous roles and wide applications in the field of medicinal chemistry. Among them, quinazoline derivatives have been found to be exhibit various diverse broad pharmacological activities such as antibacterial, antifung

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fb93da26247122fa10acaab131852691
https://doi.org/10.21276/apjhs.2021.8.2.12

Zobrazit plný text záznamu

Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan

Autor: Pritesh R. Patel, Iryna Mialik, Jaime Holden, John P. Galvin, Jeremy J. Johnson, Gregory S. Calip, Karen Sweiss, Paulina Lewkowski, Damiano Rondelli

Publikováno v: Journal of Oncology Pharmacy Practice. 27:579-587

The reduced-intensity conditioning regimen, fludarabine and melphalan 140 mg/m2 (FM140), is widely adopted in practice. Pharmacokinetic studies report 10-fold interpatient variability in melphalan exposure. We identified low hemoglobin (Hb) and/or cr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dc2cf81d123de1ee98f47205fcbf87d
https://doi.org/10.1177/1078155220927436

Zobrazit plný text záznamu

Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant

Autor: Nadim Mahmud, Gregory S. Calip, Damiano Rondelli, Karen Sweiss, Pritesh R. Patel, Bhaskar Vemu, Eric Wenzler, John P. Galvin, Craig C. Hofmeister, Jeremy J. Johnson

Publikováno v: Br J Clin Pharmacol

AIMS: High dose melphalan (HDM) and autologous stem cell transplant (ASCT) is standard of care for multiple myeloma (MM), but there is significant variability in melphalan exposure (area under the plasma drug concentration–time curve, AUC) when usi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339f8270dbf7997385daa553a13b9194
https://doi.org/10.1111/bcp.14308

Zobrazit plný text záznamu

Targets of biologic disease‐modifying antirheumatic drugs and risk of multiple myeloma

Autor: Gregory S. Calip, Todd A. Lee, Jifang Zhou, Zhaoju Wu, Alemseged Ayele Asfaw, Pritesh R. Patel, Karen Sweiss, Sruthi Adimadhyam, Brian C.-H. Chiu

Publikováno v: Int J Cancer

Several commonly used immune-suppressing biologic drugs target proteins and cytokines involved in myeloma pathogenesis. Our objective was to determine whether targeted biologic disease-modifying antirheumatic drugs (DMARDs) are associated with risk o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f760f9e62050543c758e0d99ee6f76cb
https://doi.org/10.1002/ijc.32891

Zobrazit plný text záznamu

Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma

Autor: Ali Alobaidi, Brian Talon, Naomi Y. Ko, Alemseged Ayele Asfaw, Gregory S. Calip, Brian C.-H. Chiu, Pritesh R. Patel, Jifang Zhou, Lisa K. Sharp, Karen Sweiss, Nadia A. Nabulsi

Publikováno v: Support Care Cancer

PURPOSE: To examine the impact of pre-diagnosis depressive symptoms and mental health-related quality of life (HRQOL) on survival among older patients with multiple myeloma (MM). METHODS: We performed a retrospective cohort study using the Surveillan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e613176aaa61933a9418c64b9567f6a
https://doi.org/10.1007/s00520-019-05246-6

Zobrazit plný text záznamu

My Beautiful Boy

Autor: Pritesh R. Patel

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(31)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301054ebb12907c8e8b3ab91b22a4843
https://pubmed.ncbi.nlm.nih.gov/34383577

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání